Recently a vaccine against staphylococcus aureus - a super bacterium was co-developed by the Third Military Medical University and a local pharmaceutical enterprise and got the approval of China Food and Drug Administration.

This recombinant staphylococcus aureus vaccine, the very first developed by China, can effectively prevent and cure the infection of staphylococcus aureus and enhance the infection control capacity of the army. 

Due to the abuse of antibiotics, staphylococcus aureus among other bacteria has developed an extensive drug resistance and are called super bacteria, which endanger the health of the humans. 

Zou Quanming, director of the research team of the Third Military Medical University, said: “Compared with other vaccines against super bacteria, this vaccine is more effective. It can not only cover the shortage of toxic and side effects of other vaccines but also reduce the cost. Vaccinated only three times within seven days, the recipients can effectively prevent themselves from infection of staphylococcus aureus.”

The vaccine is undergoing clinical trials and has obtained nine national patents.